# Integrated PET/MR Imaging With Amino Acid Radiotracers in the Evaluation of Brain Neoplasms: Assessing Diagnostic Accuracy and Therapeutic Response

> **NCT07211360** · — · NOT_YET_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 270 (estimated)

## Conditions studied

- Primary and Secondary Brain Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07211360
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2028-09
- **Final completion:** 2031-09
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211360, "Integrated PET/MR Imaging With Amino Acid Radiotracers in the Evaluation of Brain Neoplasms: Assessing Diagnostic Accuracy and Therapeutic Response". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07211360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*